For more information on pursuing trade policy interests through the legislative process, please contact Nicole Bivens Collinson at (202) 730-4956 or via email.
Supply Chains. The Stopping Hindrances to Invigorate Ports and Increase Trade Act (S. 3807, introduced March 10 by Sen. Lee, R-Utah) seeks to provide relief from supply chain backlogs through a number of measures, including temporary Jones Act waivers for vessels transporting cargo from one U.S. port to another to relieve congestion, identifying federal land that could temporarily be used to store and transfer empty cargo containers, temporarily eliminating import tariffs on truck chassis from certain countries, and requiring a discussion on the long-term feasibility of using inland ports for cargo container storage and transfer.
Russia. S. 3786 (introduced March 8 by Sens. Wyden, D-Ore., and Crapo, R-Idaho) and H.R. 7014 (introduced March 9 by Rep. Brady, R-Texas) would suspend normal trade relations treatment for Russia and Belarus and block all imports from Russia of oil, gas, coal, and other energy products after a 45-day transition period, codifying actions taken recently by President Biden. On March 9 the House approved H.R. 6968, which would prohibit imports of energy products from Russia.
H.R. 6995 (introduced March 8 by Rep. Perry, R-Va.), would prohibit trade with Russia, while H.R. 7044 (introduced March 9 by Perry) would prohibit imports of nickel and copper from Russia.
AD/CV Duties. The Emergency Relief from Duties Act (H.R. 7010, introduced March 9 by Rep. Mann, R-Kan., and S. 3812, introduced March 10 by Sen. Marshall, R-Kan.) would provide a temporary waiver of antidumping and countervailing duties relating to fertilizer or fertilizer ingredients if they impact the domestic production or supply of goods subject to those duties.
Trade Officials. The Senate voted March 10 to confirm Maria Pagán to be deputy U.S. trade representative at the World Trade Organization.
Foreign Drug Makers. H.R. 7006 (introduced March 9 by Rep. Griffith, R-Va.) would amend the Federal Food, Drug, and Cosmetic Act to improve inspections of foreign drug manufacturing establishments.
Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.